These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 39273139)

  • 21. A Novel Anti-CD44 Variant 9 Monoclonal Antibody C
    Tawara M; Suzuki H; Goto N; Tanaka T; Kaneko MK; Kato Y
    Curr Issues Mol Biol; 2023 Apr; 45(4):3658-3673. PubMed ID: 37185762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti‑EGFR monoclonal antibody 134‑mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
    Hosono H; Takei J; Ohishi T; Sano M; Asano T; Sayama Y; Nakamura T; Yanaka M; Kawada M; Harada H; Kaneko MK; Kato Y
    Int J Mol Med; 2020 Oct; 46(4):1443-1452. PubMed ID: 32945346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C
    Asano T; Kaneko MK; Takei J; Tateyama N; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):156-161. PubMed ID: 34283655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C
    Suzuki H; Tawara M; Hirayama A; Goto N; Tanaka T; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Jun; 43(3):85-89. PubMed ID: 38507669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H
    Tanaka T; Suzuki H; Ohishi T; Kaneko MK; Kato Y
    Cancer Sci; 2024 Jan; 115(1):298-309. PubMed ID: 37942574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody.
    Goto N; Suzuki H; Ohishi T; Harakawa A; Li G; Saito M; Takei J; Tanaka T; Asano T; Sano M; Kawada M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):67-73. PubMed ID: 35377239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG
    Kawabata H; Ohishi T; Suzuki H; Asano T; Kawada M; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):320-327. PubMed ID: 35483055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HER2 Cancer-Specific mAb, H
    Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39125956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG
    Asano T; Tanaka T; Suzuki H; Li G; Ohishi T; Kawada M; Yoshikawa T; Kaneko MK; Kato Y
    Antibodies (Basel); 2022 Nov; 11(4):. PubMed ID: 36546899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defucosylated Monoclonal Antibody (H
    Suzuki H; Ohishi T; Nanamiya R; Kawada M; Kaneko MK; Kato Y
    Curr Issues Mol Biol; 2023 Sep; 45(10):7734-7748. PubMed ID: 37886932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
    Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models.
    Tanaka T; Ohishi T; Asano T; Takei J; Nanamiya R; Hosono H; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells.
    Masuko K; Okazaki S; Satoh M; Tanaka G; Ikeda T; Torii R; Ueda E; Nakano T; Danbayashi M; Tsuruoka T; Ohno Y; Yagi H; Yabe N; Yoshida H; Tahara T; Kataoka S; Oshino T; Shindo T; Niwa S; Ishimoto T; Baba H; Hashimoto Y; Saya H; Masuko T
    PLoS One; 2012; 7(1):e29728. PubMed ID: 22272243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cancer-specific anti-podocalyxin monoclonal antibody (60-mG
    Kaneko MK; Ohishi T; Kawada M; Kato Y
    Biochem Biophys Rep; 2020 Dec; 24():100826. PubMed ID: 33088928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C
    Takei J; Asano T; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):219-226. PubMed ID: 34678095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44v10, osteopontin and lymphoma growth retardation by a CD44v10-specific antibody.
    Megaptche AP; Erb U; Büchler MW; Zöller M
    Immunol Cell Biol; 2014 Sep; 92(8):709-20. PubMed ID: 24935458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf).
    Li G; Suzuki H; Takei J; Asano T; Sano M; Tanaka T; Harada H; Mizuno T; Ohishi T; Kawada M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):53-58. PubMed ID: 35471048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma.
    Funahashi SI; Kawai S; Fujii E; Taniguchi K; Nakano K; Ishikawa S; Aburatani H; Suzuki M
    J Biochem; 2018 Dec; 164(6):471-481. PubMed ID: 30239818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Anti-HER2 Monoclonal Antibody H
    Tateyama N; Asano T; Ohishi T; Takei J; Hosono H; Nanamiya R; Tanaka T; Sano M; Saito M; Kawada M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):184-190. PubMed ID: 34424760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
    Suzuki H; Ohishi T; Asano T; Tanaka T; Saito M; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.